IFN-γ upregulates several checkpoint inhibitors, such as PD-L1 and PD-L2, on the surface of tumour cells and cooperates with PD-1 to induce T cell exhaustion, thus suppressing the antitumour immune response67–69. The gene discussed is PDCD1LG2; the disease is neoplasm.